Literature DB >> 15641940

Micronized purified flavonoid fraction (MPFF): a review of its pharmacological effects, therapeutic efficacy and benefits in the management of chronic venous insufficiency.

Konstantinos Katsenis1.   

Abstract

Initially, the progression of chronic venous insufficiency is related to venous hypertension. The earliest complaints or symptoms, as well as vessel wall deterioration, valve restructuring, and, eventually, varicose veins, result not only from elevation of pressure, but also from a cascade of biochemical events related to both the macro- and the microcirculation. Thickening and remodelling of the venous wall are influenced by two parameters: abnormal shear stress and hypoxia that activate the endothelium first at the level of valve cusps and then in large veins. Hypoxia leads to activation of the endothelium and leukocyte accumulation. By inhibiting endothelial activation, micronized purified flavonoid fraction (MPFF) (Daflon 500 mg), an edema-protective agent, can prevent the inflammatory cascade resulting from the leukocyte-endothelium interaction. This subsequently delays the appearance of reflux and inhibits the initiation of the vicious circle ending in enhanced venous pressure. This is how Daflon 500 mg relieves patients from symptoms and edema and possibly also prevents the appearance of varicose veins. Rheological disturbances also play a major role in the appearance of these disorders. Furthermore, venous hypertension provokes leakage from the vessels and capillaries exhibiting increased permeability, leading to increases in hydrostatic load, and overloading of the lymphatic network, which subsequently results fluid exudation causing edema. Microcirculatory dysfunction leads to capillary damage, skin changes and venous leg ulcers. The clinical efficacy of Daflon 500 mg in venous leg ulcers has been demonstrated by several randomised controlled studies, in which the rate of ulcer healing was significantly shortened. An explanation for the ability to speed ulcer healing comes from the protection Daflon 500 mg exerts on the microcirculation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15641940     DOI: 10.2174/1570161052773870

Source DB:  PubMed          Journal:  Curr Vasc Pharmacol        ISSN: 1570-1611            Impact factor:   2.719


  22 in total

1.  Secondary Varicose Small Pelvic Veins and Their Treatment with Micronized Purified Flavonoid Fraction.

Authors:  Yurii T Tsukanov; Anton Y Tsukanov; Evgenii G Levdanskiy
Journal:  Int J Angiol       Date:  2015-12-31

2.  Spontaneous intraventricular hemorrhage associated with prolonged diosmin therapy.

Authors:  Ramesh M Kumar; Jamie J Van Gompel; Regina Bower; Alejandro A Rabinstein
Journal:  Neurocrit Care       Date:  2011-06       Impact factor: 3.210

3.  Effects of bioflavonoids in the management of subclinical varicocele.

Authors:  Nicola Zampieri; Maristella Pellegrino; Alberto Ottolenghi; Francesco Saverio Camoglio
Journal:  Pediatr Surg Int       Date:  2010-02-17       Impact factor: 1.827

4.  The flavonoid glycosides, myricitrin, gossypin and naringin exert anxiolytic action in mice.

Authors:  Sebastian P Fernandez; Michael Nguyen; Tin Thing Yow; Cindy Chu; Graham A R Johnston; Jane R Hanrahan; Mary Chebib
Journal:  Neurochem Res       Date:  2009-04-23       Impact factor: 3.996

5.  Effect of diosmin on apoptotic signaling molecules in N-nitrosodiethylamine-induced hepatocellular carcinoma in experimental rats.

Authors:  Srinivasan Perumal; Kulanthaivel Langeshwaran; Jayaraman Selvaraj; Rajagopal Ponnulakshmi; B Shyamaladevi; M P Balasubramanian
Journal:  Mol Cell Biochem       Date:  2018-02-26       Impact factor: 3.396

Review 6.  Topical Sevoflurane: A Novel Treatment for Chronic Pain Caused by Venous Stasis Ulcers.

Authors:  Mayank Aranke; Cynthia T Pham; Melis Yilmaz; Jason K Wang; Vwaire Orhurhu; Daniel An; Elyse M Cornett; Alan David Kaye; Anh L Ngo; Farnad Imani; Reza Farahmand Rad; Giustino Varrassi; Omar Viswanath; Ivan Urits
Journal:  Anesth Pain Med       Date:  2021-02-24

7.  Influence of antioxidant complex on the adhesion of leukocytes in chronic venous insufficiency of lower limbs in rats.

Authors:  Mark Plotnikov; Ivan Ivanov; Anastasia Sidehmenova; Oleg Aliev; Nonna Tykavkina
Journal:  Indian J Pharmacol       Date:  2012 Nov-Dec       Impact factor: 1.200

8.  A Systematic Review of the Efficacy of Centella asiatica for Improvement of the Signs and Symptoms of Chronic Venous Insufficiency.

Authors:  Nyuk Jet Chong; Zoriah Aziz
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-21       Impact factor: 2.629

9.  Impact of lower extremity venous ulcers due to chronic venous insufficiency on quality of life.

Authors:  Sotirios A Koupidis; Kosmas I Paraskevas; Vassilios Stathopoulos; Dimitri P Mikhailidis
Journal:  Open Cardiovasc Med J       Date:  2008-11-28

10.  Confirmation of diosmetin 3-O-glucuronide as major metabolite of diosmin in humans, using micro-liquid-chromatography-mass spectrometry and ion mobility mass spectrometry.

Authors:  Luigi Silvestro; Isabela Tarcomnicu; Constanta Dulea; Nageswara Rao B N Attili; Valentin Ciuca; Dan Peru; Simona Rizea Savu
Journal:  Anal Bioanal Chem       Date:  2013-08-16       Impact factor: 4.142

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.